Mounkaila Noma Selected Research

Apolipoproteins C (ApoC)

6/2016	Progress towards onchocerciasis elimination in the participating countries of the African Programme for Onchocerciasis Control: epidemiological evaluation results.
5/2015	Managing the Fight against Onchocerciasis in Africa: APOC Experience.
1/2015	African Program for Onchocerciasis Control 1995-2010: Impact of Annual Ivermectin Mass Treatment on Off-Target Infectious Diseases.
7/2014	The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (2) pre-control endemicity levels and estimated number infected.
7/2014	The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (1) priority areas for ivermectin treatment.
1/2013	African Programme For Onchocerciasis Control 1995-2015: model-estimated health impact and cost.
2/2012	Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mounkaila Noma Research Topics

Disease

8	Onchocerciasis 06/2016 - 09/2011
3	Infections 06/2016 - 02/2012
1	Macular Edema 01/2022
1	Rheumatoid Arthritis 01/2021
1	Type 2 Diabetes Mellitus (MODY) 04/2020
1	Filarial Elephantiasis (Lymphatic Filariasis) 01/2015
1	Helminthiasis (Helminthiases) 01/2015
1	Ascariasis 01/2015
1	Communicable Diseases (Infectious Diseases) 01/2015
1	Parasitic Diseases (Parasitic Disease) 01/2015
1	Scabies (Sarcoptic Mange) 01/2015
1	Strongyloidiasis 01/2015
1	Trichuriasis 01/2015
1	Loiasis 09/2011

Drug/Important Bio-Agent (IBA)

7	Apolipoproteins C (ApoC)IBA 06/2016 - 02/2012
7	Ivermectin (Mectizan)FDA Link 06/2016 - 09/2011
1	Vascular Endothelial Growth FactorsIBA 01/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 04/2020

Therapy/Procedure

1	Mass Drug Administration 02/2012